Literature DB >> 22517468

Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009.

Graziano Ceresini1, Luigi Corcione, Maria Michiara, Paolo Sgargi, Giulio Teresi, Annalisa Gilli, Elisa Usberti, Enrico Silini, Gian Paolo Ceda.   

Abstract

BACKGROUND: The incidence of thyroid cancer is increasing in several countries. However, the issue of whether this applies to all different histological types and related variants is poorly addressed.
METHODS: All incident thyroid cancers diagnosed between 1998 and 2009 in a mildly iodine-deficient area in northern Italy were derived from a population-based tumor registry. Stage of disease, size of the tumor, focality, and histological variants were recorded from a review of pathology reports and slides. The mean annual increase (MAI) of the standardized incidence rate was calculated over the entire 12-year period of observation and a standardized rate ratio was evaluated to compare the mean standardized incidence between 2 periods of 6 years each (1998-2003 vs 2004-2009).
RESULTS: In total, 980 cases were considered. An increase in the incidence trend for all thyroid tumors was demonstrated; the increase was found to be continuous from 1998 to 2002 but not afterward. The cancer incidence increased in both male and female subjects. Papillary thyroid carcinoma (PTC), the follicular variant of PTC, the tall cell variant of PTC (TCV-PTC), and Hurthle cell carcinoma (HC) showed the most relevant changes in incidence whereas follicular carcinoma was not found to be significantly affected. TCV-PTC was the only histological type to demonstrated a significant (P < .01) proportional increase in the second 6-year period of observation. Only TCV-PTC and HC were found to display a significant MAI after 2002.
CONCLUSIONS: The incidence of thyroid cancer has increased within the last decade, an increase that is accounted for mostly by differentiated tumors. The most significant increases were documented for aggressive variants of basic histotypes.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22517468     DOI: 10.1002/cncr.27591

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Causes of referral to the first endocrine visit of patients with thyroid carcinoma in a mildly iodine-deficient area.

Authors:  Michela Marina; Gian Paolo Ceda; Raffaella Aldigeri; Graziano Ceresini
Journal:  Endocrine       Date:  2016-10-14       Impact factor: 3.633

Review 2.  The Treatment of Well-Differentiated Thyroid Carcinoma.

Authors:  Ralf Paschke; Thomas Lincke; Stefan P Müller; Michael C Kreissl; Henning Dralle; Martin Fassnacht
Journal:  Dtsch Arztebl Int       Date:  2015-06-26       Impact factor: 5.594

3.  Pattern of nodal involvement in papillary thyroid cancer: a challenge of quantitative analysis.

Authors:  Fausto Fama; Marco Cicciù; Giuseppe Lo Giudice; Alessandro Sindoni; Jessica Palella; Arnaud Piquard; Olivier Saint-Marc; Salvatore Benvenga; Ennio Bramanti; Gabriele Cervino; Maria Gioffre Florio
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis.

Authors:  Eric J Kuo; Paolo Goffredo; Julie A Sosa; Sanziana A Roman
Journal:  Thyroid       Date:  2013-09-14       Impact factor: 6.568

5.  Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies.

Authors:  Michael B Zimmermann; Valeria Galetti
Journal:  Thyroid Res       Date:  2015-06-18

6.  Evolution of differentiated thyroid cancer: a decade of thyroidectomies in a single institution.

Authors:  Carles Zafon; Juan Antonio Baena; Josep Castellví; Gabriel Obiols; Oscar Gonzalez; José Manuel Fort; Ramon Vilallonga; Enric Caubet; Manuel Armengol; Jordi Mesa
Journal:  Eur Thyroid J       Date:  2014-08-29

7.  Reactivity of thyroid papillary carcinoma cells to thyroid stimulating hormone-dominated endocrine therapy.

Authors:  Yuqin Ma; Xia Zhang; Yutao Wang
Journal:  Oncol Lett       Date:  2017-10-11       Impact factor: 2.967

8.  Aggressiveness of the tall cell variant of papillary thyroid carcinoma is independent of the tumor size and patient age.

Authors:  Rocío Villar-Taibo; Diego Peteiro-González; José Manuel Cabezas-Agrícola; Elvin Aliyev; Francisco Barreiro-Morandeira; Clara Ruiz-Ponte; José M Cameselle-Teijeiro
Journal:  Oncol Lett       Date:  2017-03-29       Impact factor: 2.967

Review 9.  Tall cell variant of papillary thyroid carcinoma: current evidence on clinicopathologic features and molecular biology.

Authors:  Xiaofei Wang; Wenli Cheng; Chongqing Liu; Jingdong Li
Journal:  Oncotarget       Date:  2016-06-28

10.  Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China.

Authors:  Lingbin Du; Youqing Wang; Xiaohui Sun; Huizhang Li; Xinwei Geng; Minghua Ge; Yimin Zhu
Journal:  BMC Cancer       Date:  2018-03-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.